Tang Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Tang Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145M	Hold	1,236,027	–	–	6.57%	3
2026 Q1	$114M	Hold	1,236,027	–	–	5.8%	3
2025 Q4	$97.6M	Hold	1,236,027	–	–	4.82%	5
2025 Q3	$90.6M	Hold	1,236,027	–	–	3.49%	5
2025 Q2	$62.9M	Sell	1,236,027 -1,080	-0.1%	-$48.1K	3.18%	6
2025 Q1	$55.7M	Hold	1,237,107	–	–	3.08%	8
2024 Q4	$51.2M	Sell	1,237,107 -50,000	-4%	-$2.08M	3.38%	5
2024 Q3	$50.2M	Hold	1,287,107	–	–	3.59%	5
2024 Q2	$44M	Buy	1,287,107 +100,000	+8%	+$2.62M	4.48%	4
2024 Q1	$29.8M	Buy	1,187,107 +50,000	+4%	+$1.37M	3.1%	5
2023 Q4	$33.6M	Hold	1,137,107	–	–	3.1%	7
2023 Q3	$35.9M	Hold	1,137,107	–	–	5.07%	2
2023 Q2	$29.4M	Sell	1,137,107 -32,893	-3%	-$875K	4.33%	3
2023 Q1	$28.1M	Buy	1,170,000 +50,000	+4%	+$1.14M	4.19%	3
2022 Q4	$21.8M	Buy	1,120,000 +670,000	+149%	+$13.2M	3.17%	9
2022 Q3	$9.46M	Buy	450,000 +350,000	+350%	+$8.43M	1.16%	25
2022 Q2	$1.95M	Buy	+100,000	New	+$2.36M	0.3%	50

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tang Capital Management's MIRM Position: Q2 2026 in Review

Tang Capital Management held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 1,236,027 shares worth $145M. The position accounts for 6.57% of the portfolio, ranked #3.

Tang Capital Management first reported a position in MIRM in Q2 2022 and has held it in 17 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Tang Capital Management held 1,236,027 shares of Mirum Pharmaceuticals worth $145M as of Q2 2026.
Tang Capital Management left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
Mirum Pharmaceuticals made up 6.57% of Tang Capital Management's portfolio in Q2 2026, its #3 holding.
Tang Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.